# Nuoyu Capital

> Nuoyu Capital is a VC fund in Shanghai backing Health Care and Medical. See 10 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Shanghai, China
- Total investments: 10
- Last investment: Jun 2026
- Lead investor: 80%
- Last updated: Aug 2026

Nuoyu Capital is a venture capital and private equity fund that focuses on investments in medical devices and digital medical fields.

## Contacts

5 contacts available for Nuoyu Capital. Shizune tracks 1 team members at Nuoyu Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/nuoyu-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 5 | 50% |
| Medical | 4 | 40% |
| Biotechnology | 4 | 40% |
| Medical Device | 4 | 40% |
| Laser | 1 | 10% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 4 | 40% |
| Angel | 3 | 30% |
| Seed | 2 | 20% |
| Series B | 1 | 10% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Xu Linzhen | Investment Director | 1 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Mairun Medical | Mairun Medical focuses on the development of innovative medical devices in the cardiovascular field |  | Angel | Jun 15, 2026 |  |
| Ruanxin Biotechnology | Ruanxin Biotechnology focuses on the research and development of injectable cartilage technology. | $14.7M | Seed | Apr 21, 2026 |  |
| Ruiyi Xulian | Ruiyi Xulian is a medical device research and development and manufacturing company dedicated to solving major brain diseases by developing advanced medical technologies and innovative neurological treatment solutions, aiming to improve the diagnosis, treatment, and rehabilitation of patients suffering from complex brain disorders. |  | Series A | Mar 11, 2026 |  |
| Ruanxin Biotechnology | Ruanxin Biotechnology focuses on the research and development of injectable cartilage technology. |  | Series A | Feb 14, 2026 |  |
| Weican Medical | Weican Medical makes special devices that help deliver medicine inside the body without needing big surgeries. |  | Angel | Apr 11, 2025 |  |
| Femtosecond Technology | Femtosecond Technology is a developer of label-free biological imaging technology.Femtosecond Technology is a high-tech, "specialized and innovative" firm focusing on the application of femtosecond laser technology in clinical diagnosis and treatment, as well as biomedical industrialization. | $14.1M | Series A | Nov 04, 2024 |  |
| Yuewei Medical | Yuewei Medical is a developer of cardiac surgery interventional medical devices. | $14.1M | Series A | Dec 28, 2023 |  |
| Ruier Weikang | Ruier Weikang focuses on the development and commercialization of brain scientific disease diagnostic, monitoring, and therapy products. |  | Seed | Sep 12, 2023 |  |
| Huaboron Neutron | Huaboron Neutron is a biotechnology company that develops boron drugs and boron neutron capture therapy devices for the diagnosis of malignant cancers. | $14.2M | Angel | Aug 02, 2023 |  |
| Huihe Healthcare | Huihe Healthcare specializes in the development of medical devices for structural heart disease. The company was founded in 2019 and is headquartered in Shanghai, China. | $15.4M | Series B | Jul 02, 2021 |  |

10 of 10 investments shown.

## Co-investors
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund, 2 deals together
- [Oriza Seed Capital (Oriza Yuandian)](https://shizune.co/investors/profile/oriza-seed-capital) — VC Fund, 2 deals together
- [CAS Star](https://shizune.co/investors/profile/cas-star) — VC Fund, 1 deal together
- Deshi Capital — VC Fund, 1 deal together
- [Guangzhou Guoju Venture Capital](https://shizune.co/investors/profile/guangzhou-guoju-venture-capital) — VC Fund, 1 deal together
- [Guofang Capital](https://shizune.co/investors/profile/guofang-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Nuoyu Capital invest in?

Nuoyu Capital invests primarily in Health Care, Medical and Biotechnology startups, most often at Series A and Angel stage. Most of the 10 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Nuoyu Capital?

For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Nuoyu Capital?

The team at Nuoyu Capital includes Xu Linzhen (Investment Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co